Mol. Hum. Reprod. Advance Access originally published online on November 30, 2006
Molecular Human Reproduction 2007 13(1):1; doi:10.1093/molehr/gal103
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial |
Onward and upward with MHR
As incoming Editor-in-Chief of MHR, I am delighted to have this opportunity briefly to set out my stall and let you know how I see the journal developing over the next 3 years. Richard Ivell, his associate editors and the editorial support and production teams have done brilliantly in ensuring that MHR has progressively edged up its impact factor, year on year, to the recent high of 3.191. In the JCI 2005 impact factor ranking for the Reproductive Biology subject category, MHR was fourth in the world. Above all, this testifies to the success of the European Society of Human Reproduction and Embryology’s (ESHRE) publication strategy, with all three of its house journals appearing in the top quartet. The overall aim for MHR must be to continue to strive for excellence, judged not just by impact factor but also by service to its authors and readership. In particular, potential authors will want reassurance that the turn-around times from submission to decision and onwards to publication—electronic and paper—are kept to absolute minima. I pledge to work with the associate editors, peer reviewers and our production and editorial staff at MHR to drive down these metrics to all time lows.Under my Editorship, MHR will continue to fulfil its current aims and objectives on behalf of ESHRE, which I repeat here:
Molecular Human Reproduction publishes articles on the molecular aspects of human reproductive physiology and pathology, endocrinology, andrology, gonadal function, gametogenesis, fertilization, embryo development, implantation, pregnancy and contraception. Reproductive genetics is also an important part of Molecular Human Reproduction. Studies on animal models are welcome as long as a clear relevance to human reproduction can be shown. Published papers include peer-reviewed original research reports, short review articles and commentaries.
However, post-genomic reproductive (and regenerative) biomedicine is in transition and the scope and focus of MHR must adjust accordingly. Productive hypothesis and data-driven research approaches nowadays coexist, side-by-side. Basic experimental findings still inform clinical practice but increasingly data mined from patients (individuals and populations) can be used to inform basic science. MHR will strive to ensure its pages reflect the huge potential this translational flux is likely to have for improvements in global human reproductive health and our ability to diagnose and treat reproductive disorders and disease. So, whatever your piece of this action, if it is novel and makes a difference, I urge you think of submitting it to MHR!
Editor-in-Chief
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||